Abstract 481: Utility of hCG as a biomarker of treatment response in advanced urothelial cancer: A population based series at Akershus University Hospital, NorwayKatarina Puco, Jan Oldenburg, Stig Müller et al.|Cancer Research|2021Cited by 1